Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an update.
ResMed Inc’s Chairman Emeritus, Peter C. Farrell, reported a transaction involving the disposal of 2,000 shares of ResMed common stock at a price of $230.99 per share under a pre-established Rule 10b5-1 plan. This transaction reflects ongoing management of ownership stakes by key company figures, potentially impacting investor perceptions and the company’s market dynamics.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc operates in the healthcare industry, focusing on the development, manufacturing, and distribution of equipment for sleep disorders, respiratory care, and other chronic diseases.
YTD Price Performance: -0.03%
Average Trading Volume: 930,235
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$54.7B
For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.
